Related News

May 7, 2020

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 7 months, Genomic Health I has returned 8.85% as of today's recent price of $63.44.

In...

April 29, 2020

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 7 months, Genomic Health I has returned 0.23% as of today's recent price of $69.76.

...

April 22, 2020

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 7 months, Genomic Health I has returned 0.23% as of today's recent price of $69.76.

In...

April 14, 2020

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 7 months, Genomic Health I has returned 0.23% as of today's recent price of $69.76.

...

April 13, 2020

Below are the three companies in the Biotechnology industry with the highest price to cash flow ratios. Often companies with the lowest ratio present the greatest value to investors.

Chemocentryx Inc ranks highest with a a price to cash...

April 2, 2020

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

April 2, 2020

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

March 31, 2020

Below are the three companies in the Biotechnology industry with the lowest sales growth.

Myriad Genetics ranks lowest with a sales growth of 233.5%. Following is Genomic Health I with a sales growth of 392.9%. Biospecifics Tec ranks...

March 30, 2020

Below are the three companies in the Biotechnology industry with the highest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the...

March 25, 2020

Below are the three companies in the Biotechnology industry with the lowest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar...